PYS Ex-Dividend Reminder - 10/9/13

Looking at the universe of stocks we cover at Dividend Channel, on 10/9/13, Merrill Lynch Depositor Incorporated (PYS) will trade ex-dividend, for its semi-annual dividend of $0.7875, payable on 10/15/13. As a percentage of PYS's recent stock price of $22.97, this dividend works out to approximately 3.43%, so look for shares of Merrill Lynch Depositor Incorporated to trade 3.43% lower — all else being equal — when PYS shares open for trading on 10/9/13.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for PYS, showing historical dividends prior to the most recent $0.7875 declared by Merrill Lynch Depositor Incorporated:

PYS+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from PYS is likely to continue, and whether the current estimated yield of 6.86% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of PYS shares, versus its 200 day moving average:

Merrill Lynch Depositor Incorporated 200 Day Moving Average Chart

Looking at the chart above, PYS's low point in its 52 week range is $22.22 per share, with $25.00 as the 52 week high point — that compares with a last trade of $22.97.

In Monday trading, Merrill Lynch Depositor Incorporated shares are currently off about 0.1% on the day.

null

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says